When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
There is plenty of discussion about AbbVie's (ABBV) recent proposal to acquire Allergan (AGN). The deal appears to be highly polarizing: some love it, some hate it. Which camp you fall into seems to depend on how much of a cynic you are. Those who love the deal see two companies with enormous cash flows and histories of generous shareholder returns. Those who hate the deal see "melting ice cubes" combining out of desperation and taking on more leverage than they can handle. Which side is right? Only the future knows.